Related Experiment Video
Updated: Jan 18, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
EPIDEMIOLOGICAL AND CLINICAL PROFILE OF CROHN'S DISEASE IN A BRAZILIAN REFERRAL CENTER IN 30 YEARS OF FOLLOW-UP
Igor Nolasco Segheto1, Francisco Guilherme Cancella Penna2, Sophia Campos Salles Silva de Carvalho3
1Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil.
Background:
Crohn's disease (CD) is a chronic inflammatory disease, with a heterogeneous clinical course, which can affect any segment of the gastrointestinal tract. Data on the natural history of CD in developing countries are rare.
Objective:
to delineate the clinical, epidemiological, and longitudinal characteristics of CD patients at a Brazilian referral center.
Methods:
this is an observational, cohort, retrospective study, carried out from the collection of data obtained from the medical records of individuals diagnosed with CD followed up in the period between 1991 and 2021.
Results:
A total of 328 participants were included, 54.3% female. The median age at diagnosis was 31 years [interquartile range (IQR)=14-45]. At diagnosis, there was a predominance of the stricturing form (38.7%) and ileocolonic location (53.7%). Among the patients with the inflammatory form, 10.8% evolved to the stricturing or penetrating forms, and the time they remained with uncomplicated disease had a median of 6 years (IQR=0-13). Aminosalicylates were used in 70.7% of the patients, but there has been a reduction in their use in the last 15 years (P=0.04). Corticosteroids were used in 90.2% of the participants, with a median time of use of 12 months (IQR=0-36). Immunosuppressants were used in 93.9% of participants. Two hundred and ten patients (64%) received treatment with immunobiological. The median interval between diagnosis and initiation of biological therapy was 24 months (IQR=12-60). One hundred and eighty-nine patients (57.6%) were hospitalized during follow-up, and the median hospital stay was 20 days (IQR=11-36). In the last 15 years, there was a decrease in the hospitalization rate (P<0.001), but there was no change in the number of hospitalizations per patient (P=0.62). One hundred and fifty-two patients (46.3%) underwent surgical treatment during the period evaluated and the most frequently performed surgeries were enterectomies (26.8%) and perianal procedures (25%). In the last 15 years, there has been a decrease in the rate of surgeries (P=0.04) and in the number of surgeries per patient (P<0.001).
Conclusion:
The data presented indicate a high prevalence of complicated CD at the onset of follow-up, alongside a significant percentage of corticosteroid use and hospitalization. However, over the past 15 years, there has been a notable reduction in hospitalization rates, surgical rates, and the number of surgeries per patient.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

